LONG-TERM SAFETY OF ADALIMUMAB IN CLINICAL TRIALS IN ADULT PATIENTS WITH CROHN’S DISEASE OR ULCERATIVE COLITIS

(1) Icahn School of Medicine at Mount Sinai,New York,United States

(2) University of Calgary,Calgary,Canada

(3) University of California at San Diego,La Jolla,United States

(4) University of Leuven,Leuven,Belgium

(5) University of Chicago Medical Center,Chicago,United States

(6) McMaster University,Hamilton,Canada

(7) Inserm U954 and Department of Gastroenterology, Université de Lorraine,Vandoeuvre-les-Nancy,France

(8) AbbVie Inc.,North Chicago,United States



This item was part of UEG Week 2015

This item can be cited as: United European Gastroenterology Journal; 2015: 2 (Supplement 1)